We’re proud to announce that Max International has been invited to the 1st International Conference of Medical Biology and 3rd International Symposium of Biological Therapies and Homotoxicology in Buenos Aires, Argentina to present on RiboCeine™ and glutathione. RiboCeine is revolutionizing the health and wellness industry and scientists and physicians everywhere are starting to take notice.
We're excited to be at the beautiful city of Buenos Aires
This international event will be hosted by the Argentinean Medical Association and seeks to address and discuss new methodologies of diagnosing and new, alternatives for treating disabling diseases that affect children, adults, and the elderly. The doctors and researchers attending the event have recognized the amazing potential of RiboCeine as the first endogenous molecule that can produce intracellular glutathione. Dr. Herb Nagasawa, Ph.D., the creator of RiboCeine, will highlight the science behind this breakthrough technology as part of the “New Paradigms in the Diagnosis and Treatments of Disabilities” program. RiboCeine will also be featured in a training workshop that will investigate its potential therapeutic applications.
Dr. Herb Nagasawa
Max International is excited to send its product development team, Executive Director of Product Development Scott Nagasawa and the Executive Director of Product Management Scott Momii, along with Max International’s Co-CEOs Dave Bagley and Joe Voyticky to attend the event. We’re very honored to be presenting at this event and look forward to continue sharing RiboCeine with the world.
It’s the hard work and dedication of our Associates that is spreading our products throughout the globe and helped make this recognition possible. You can all take pride in the good work that you’re doing every day!
The International Conference and Symposium is scheduled for November 8 – 10, 2012 and will be held at the main office of the Argentine Medical Association in Buenos Aires, Argentina. We’ll be sure to have more updates during the event and will provide a full recap after it’s over.
Max International Has Been Invited to Present on RiboCeine™ at the International Conference and Symposium in Argentina is a post from: